caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1124025853

Kenneth HallOD

PRACTICECLARKSON OPTOMETRY MIDWEST INC.See all providers at this practice →
OptometryLouisville, KYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Kenneth Hall's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BAPTIST HEALTHCARE SYSTEM INC.1935
Killer Bees Llc
Ambulatory Surgical Center · Louisville, KY
1113
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Killer Bees Llc
Ambulatory Surgical Center · Louisville, KY
1841
BAPTIST HEALTHCARE SYSTEM INC.1735
Laboratory Corporation Of America Holdings
Clinical Laboratory · Dublin, OH
1322
Kyle Goldsmith
Certified Registered Nurse Anesthetist (CRNA) · Louisville, KY
1227
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,269
Unique beneficiaries
—
Total services
4,968
Distinct HCPCS
14
Medicare payment
$89K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 553 Optometry providers in KY — top quintile (cohort median 1,238).
PRESCRIBING · PART D · 2024
Total Rx claims
173
Beneficiaries
—
Total drug cost
$1K
Distinct drugs
2
Brand share
24.3%
Top prescribed drugs
Latanoprost131 claims
Neomycin/Polymyxin B/Dexametha42 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.